{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:05:34Z","timestamp":1790075134414,"version":"4.0.1"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neuro-Oncol"],"published-print":{"date-parts":[[1994]]},"DOI":"10.1007\/bf01057964","type":"journal-article","created":{"date-parts":[[2005,1,31]],"date-time":"2005-01-31T17:08:34Z","timestamp":1107191314000},"page":"81-95","source":"Crossref","is-referenced-by-count":13,"title":["The application of 5-bromodeoxyuridine in the management of CNS tumors"],"prefix":"10.1007","volume":"20","author":[{"given":"Andrew","family":"Freese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"O'Rourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Judy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"12","key":"CR1","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/carcin\/11.12.2245","volume":"11","author":"SR Eldridge","year":"1990","unstructured":"Eldridge SR, Tilbury LF, Goldsworthy TL, Butterworth E: Measurement of chemically induced cell proliferation in rodent liver and kidney: a comparison of 5-bromo-2?-deoxyuridine and ['3H] thymidine administered by injection or osmotic pump. Carcinogenesis 11(12): 2245?2251, 1990","journal-title":"Carcinogenesis"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3171\/jns.1972.37.1.0015","volume":"37","author":"T Hoshino","year":"1972","unstructured":"Hoshino T, Barker M, Wilson CB, Boldrey EB, Fewer D: Cell kinetics of human gliomas. J Neurosurg 37: 15?26, 1972","journal-title":"J Neurosurg"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3171\/jns.1986.65.5.0659","volume":"65","author":"Y Yoshii","year":"1986","unstructured":"Yoshii Y, Maki Y, Tsuboi K, Tomono Y, Nakagawa K, Hoshino T: Estimation of growth fraction with bromodeoxyuridine in human central nervous system tumors. J Neurosurg 65: 659?663, 1986","journal-title":"J Neurosurg"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0022-2836(59)80038-3","volume":"1","author":"E Freese","year":"1959","unstructured":"Freese E: The specific mutagenic effect of base analogues on Phage T4. J Mol Biol 1: 87?105, 1959","journal-title":"J Mol Biol"},{"issue":"4","key":"CR5","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1073\/pnas.45.4.622","volume":"45","author":"E Freese","year":"1959","unstructured":"Freese E: The difference between spontaneous and baseanalogue induced mutations of Phage T4. Proc Natl Acad Sci, USA 45(4): 622?633, 1959","journal-title":"Proc Natl Acad Sci, USA"},{"issue":"4","key":"CR6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3171\/jns.1988.69.4.0500","volume":"69","author":"HS Greenberg","year":"1988","unstructured":"Greenberg HS, Chandler WF, Diaz RF, Ensminger WD, Junck L, Page MA, Gebarski SS, McKeever P, Hood TW, Stetson PL, Litchter AS, Tankanow R: Intra-arterial bromodeoxyuridine radiosensitization and radiation in treatment of malignant astrocytomas. J Neurosurg 69(4): 500?505, 1988","journal-title":"J Neurosurg"},{"key":"CR7","first-page":"539","volume":"58","author":"W Szybalzski","year":"1974","unstructured":"Szybalzski W: X-ray sensitization by halopyrimidines. Cancer Chemother Rep 58: 539?557, 1974","journal-title":"Cancer Chemother Rep"},{"issue":"1?2","key":"CR8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0027-5107(91)90197-V","volume":"250","author":"H Hoppe","year":"1991","unstructured":"Hoppe H, Call KM, Leong PM, Thilly WG: Cell-cycle dependent mutation of human lymphoblasts: bromodeoxyuridine and butyl methanesulfonate. Mutat Res 250(1?2): 411?421, 1991","journal-title":"Mutat Res"},{"issue":"3","key":"CR9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3171\/jns.1988.69.3.0371","volume":"69","author":"T Nishizaki","year":"1988","unstructured":"Nishizaki T, Orita T, Saiki M, Furutani Y, Aoki H: Cell kinetics studies of human brain tumors byin vitro labeling using anti-BUdR monoclonal antibody. J Neurosurg 69(3): 371?374, 1988","journal-title":"J Neurosurg"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1126\/science.7123245","volume":"218","author":"HG Gratzner","year":"1982","unstructured":"Gratzner HG: Monoclonal antibody to 5-bromo and 5-iododeoxyuridine: a new reagent for the detection of DNA replication. Science 218: 474?475, 1982","journal-title":"Science"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3171\/jns.1988.68.5.0806","volume":"68","author":"HP Charman","year":"1988","unstructured":"Charman HP, Lowenstein DH, Cho KG, DeArmond SJ, Wilson CB: Primary cerebral angiosarcoma. J Neurosurg 68: 806?810, 1988","journal-title":"J Neurosurg"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3171\/jns.1986.65.6.0790","volume":"65","author":"KG Cho","year":"1986","unstructured":"Cho KG, Hoshino T, Nagashima T, Murovic JA, Wilson CB: Prediction of tumor doubling time in recurrent meningiomas. J Neurosurg 65: 790?794, 1986","journal-title":"J Neurosurg"},{"issue":"6","key":"CR13","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/1097-0142(19910315)67:6<1629::AID-CNCR2820670626>3.0.CO;2-E","volume":"67","author":"T Fujimaki","year":"1991","unstructured":"Fujimaki T, Matsutani M, Nakamura O, Asai A, Funada N, Koike M, Segawa H, Aritake K, Fukushima T, Houjo S, Tawura A, Sano K: Correlation between bromodeoxyuridine-labeling indices and patent prognosis in cerebral astrocytic tumors of adults. Cancer 67(6): 1629?1634, 1991","journal-title":"Cancer"},{"issue":"3?4","key":"CR14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01401236","volume":"81","author":"M Fukui","year":"1986","unstructured":"Fukui M, Iwaki T, Sawa H, Inoue T, Takeshita I, Kitamura K: Proliferative activity of meningiomas as evaluated by bromodeoxyuridine uptake examination. Acta Neurochir (Wien) 81(3?4): 135?141, 1986","journal-title":"Acta Neurochir (Wien)"},{"issue":"6","key":"CR15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/cyto.990060619","volume":"6","author":"T Hoshino","year":"1985","unstructured":"Hoshino T, Nagashima T, Murovic J, Levin EM, Levin VA, Rupp SM: Cell kinetic studies ofin situ human brain tumors with bromodeoxyuridine. Cytometry 6(6): 627?632, 1985","journal-title":"Cytometry"},{"issue":"7","key":"CR16","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/1097-0142(19861001)58:7<1466::AID-CNCR2820580715>3.0.CO;2-W","volume":"58","author":"T Hoshino","year":"1986","unstructured":"Hoshino T, Nagashima T, Murovic JA, Wilson CB, Davis RL: Proliferative potential of human meningiomas of the brain: A cell kinetics study with bromodeoxyuridine. Cancer 58(7): 1466?1472, 1986","journal-title":"Cancer"},{"issue":"3","key":"CR17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3171\/jns.1986.64.3.0453","volume":"64","author":"T Hoshino","year":"1986","unstructured":"Hoshino T, Nagashima T, Murovic JA, Wilson CB, Edwards MS, Gutin PH, Davis RL, DeArmond SJ:in situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling. J Neurosurg 64(3): 453?459, 1986","journal-title":"J Neurosurg"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3171\/jns.1988.69.6.0839","volume":"69","author":"T Hoshino","year":"1988","unstructured":"Hoshino T, Rodriguez LA, Cho KG, Lee KS, Wilson CB, Edwards MSB, Levin V, Davis RL: Prognostic implications of the proliferative potential of low-grade astrocytomas. J Neurosurg 69: 839?842, 1988","journal-title":"J Neurosurg"},{"issue":"3","key":"CR19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00688188","volume":"74","author":"T Iwaki","year":"1987","unstructured":"Iwaki T, Takeshita I, Fukui M, Kitamura K: Cell kinetics of the malignant evolution of meningiothelial meningioma. Acta Neuropathol (Berl) 74(3): 243?247, 1987","journal-title":"Acta Neuropathol (Berl)"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3171\/jns.1991.75.2.0202","volume":"75","author":"F Labrousse","year":"1991","unstructured":"Labrousse F, Daumas-Duport C, Batorski L, Hoshino T: Histological grading and bromodeoxyuridine.labeling index of astrocytomas. J Neurosurg 75: 202?205, 1991","journal-title":"J Neurosurg"},{"issue":"3","key":"CR21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF00294650","volume":"80","author":"KS Lee","year":"1990","unstructured":"Lee KS, Hoshino T, Rodriguez LA, Bederson J, Davis RL, Wilson CB: Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence. Acta Neuropathol (Berl) 80(3): 311?317, 1990","journal-title":"Acta Neuropathol (Berl)"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3171\/jns.1986.65.3.0331","volume":"65","author":"JA Murovic","year":"1986","unstructured":"Murovic JA, De Armond S, Nagashima T, Edwards MSB, Hoshino T: Cell kinetics analysis in a case of teratoma of the thoracic spine. J Neurosurg 65: 331?334, 1986","journal-title":"J Neurosurg"},{"issue":"1?2","key":"CR23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00688136","volume":"67","author":"T Nagashima","year":"1985","unstructured":"Nagashima T, DeArmond SJ, Murovic J, Hoshino T: Immunocytochernical demonstration of S-phase cells by antibromodeoxyuridine monoclonal antibody in human brain tumor tissues. Acta Neuropathol (Berl) 67 (1?2): 155?159, 1985","journal-title":"Acta Neuropathol (Berl)"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3171\/jns.1988.68.3.0388","volume":"68","author":"T Nagashima","year":"1988","unstructured":"Nagashima T, Hoshino T, Cho JG, Senegor M, Waldman F, Nomura K: Comparison of bromodeoxyuridine labeling indices obtained from tissue sections and flow cytometry of brain tumors. J Neurosurg 68: 388?392, 1988","journal-title":"J Neurosurg"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3171\/jns.1986.64.4.0588","volume":"64","author":"T Nagashima","year":"1986","unstructured":"Nagashima T, Murovic JA, Hoshino T, Wilson CB, DeArmond SJ: The proliferative potential of human pituitary tumorsin situ. J Neurosurg 64: 588?593, 1986","journal-title":"J Neurosurg"},{"issue":"3","key":"CR26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00172481","volume":"13","author":"MD Prados","year":"1992","unstructured":"Prados MD, Krouwer HG, Edwards MS, Cogen PH, Davis RL, Hoshino T: Proliferative potential and outcome in pediatric astrocytic tumors. J Neurooncol 13 (3): 277?282, 1992","journal-title":"J Neurooncol"},{"issue":"4","key":"CR27","first-page":"494","volume":"30","author":"M Shibuya","year":"1992","unstructured":"Shibuya M, Hoshino T, Ito S, Wacker MR, Prados MD, Davis RL, Wilson CB: Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling. Neurosurgery 30(4): 494?497, 1992","journal-title":"Neurosurgery"},{"issue":"1?2","key":"CR28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF01402189","volume":"102","author":"T Tashima","year":"1990","unstructured":"Tashima T, Fukui M, Nishio S, Fujii K, Iwaki T: Radiationinduced meningiomas and their proliferative activity. Cytokinetic study using bromodeoxyuridine. Acta Neurochir (Wien) 102(1?2): 69?72, 1990","journal-title":"Acta Neurochir (Wien)"},{"issue":"4","key":"CR29","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3171\/jns.1992.76.4.0705","volume":"76","author":"Y Uematsu","year":"1992","unstructured":"Uematsu Y, Yukawa S, Yokote H, Itakura T, Hayashi S, Komai N: Meningeal melanocytoma: magnetic resonance imaging characteristics and pathological features. Case report. J Neurosurg 76(4): 705?709, 1992","journal-title":"J Neurosurg"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1084\/jem.112.3.509","volume":"112","author":"B Djordjevic","year":"1960","unstructured":"Djordjevic B, Szybalszki W: Genetics of human cell lines III: Incorporation of 5 bromo and 5 iododeoxyuridine into the DNA of human cells and its effect on radiation sensitivity. J Exp Med 112: 509?531, 1960","journal-title":"J Exp Med"},{"issue":"1","key":"CR31","first-page":"33","volume":"6","author":"M Matsutani","year":"1988","unstructured":"Matsutani M, Kohno T, Nagashima T, Nagayama I, Matsuda T, Hoshino T, Sano K: Clinical trial of intravenous infusion of bromodeoxyuridine [BUdR] for radiosensitization of malignant brain tumors. Radiat Med 6(1): 33?39, 1988","journal-title":"Radiat Med"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/0360-3016(87)90194-5","volume":"13","author":"RW Miller","year":"1987","unstructured":"Miller RW, DeGraff W, Kinsella TJ, Mitchell JB: Evaluation of incorporated iododeoxyuridine cellular radiosensitization by photon activation therapy. In J Radiat Oncol Biol Phys 13: 1193?1197, 1987","journal-title":"In J Radiat Oncol Biol Phys"},{"issue":"3","key":"CR33","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0161-6420(90)32593-9","volume":"97","author":"JF Vander","year":"1990","unstructured":"Vander JF, Kincaid MC, Hegarty TJ, Page M, Averill D, Junck L, Greenberg HS: The ocular effects of intracarotid bromodeoxyuridine and radiation therapy in the treatment of malignant glioma. Ophthalmology 97(3): 352?357, 1990","journal-title":"Ophthalmology"},{"issue":"9","key":"CR34","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1128\/jb.172.9.5278-5285.1990","volume":"172","author":"Y Yamamoto","year":"1990","unstructured":"Yamamoto Y, Fujiwara Y: Uracil-DNA glycosylase causes 5-bromodeoxyuridine photosensitization inEscherichia coli K-12. J Bacteriol 172(9): 5278?5285, 1990","journal-title":"J Bacteriol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0360-3016(91)90108-G","volume":"20","author":"RJ Kinsella","year":"1991","unstructured":"Kinsella RJ, Gould MN, Mulcahy T, Ritter MA, Fowler JF: Keynote address: Integration of cytostatic agents and radiation therapy: a different approach to ?proliferating? human tumors. Int J Rad Oncol Biol Phys 20: 295?302, 1991","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/05678066909172261","volume":"8","author":"T Hoshino","year":"1969","unstructured":"Hoshino T, Sano K: Radiosensitization of malignant brain tumors with bromouridine. Acta Radiol 8: 15?26, 1969","journal-title":"Acta Radiol"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0360-3016(90)90805-T","volume":"18","author":"TL Phillips","year":"1990","unstructured":"Phillips TL, Levin VA, Gutin PH, Davis RL, Wilson CB, Prados MD, Wara WM, Flam MS, Ahn DK: Evaluation of bromodeoxyuridine in glioblastoma multiforme: An NCCC Phase II study. Int J Radiat Oncol Biol Phys 18: 205, 1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR38","doi-asserted-by":"crossref","unstructured":"Phillips TL, Levin VA, Ahn DK, Gutin PH, Davis RL, Wilson CB, Prados MD, Wara WM, Flam MD: Evaluation of bromodeoxyuridine in glioblastoma multiforme: A Northern California Cancer Center Phase II Study. Int J Radiat Oncol Biol Phys 21, 1991","DOI":"10.1016\/0360-3016(91)90690-6"},{"key":"CR39","first-page":"91","volume":"9","author":"VA Levin","year":"1990","unstructured":"Levin VA, Wara WM, Gutin PH, Wilson CV, Phillips T, Prados M, Flam MS, Ahn DK: Initial analysis of NCOG 6G82-1: Bromodeoxyuridine (BUdR) during irradiation followed by CCNU, procarbazine and vincristine (PVC) chemotherapy for malignant gliomas. J Clin Oncol 9: 91, Abstract 355, 1990","journal-title":"J Clin Oncol"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00000421-198710000-00014","volume":"10","author":"D Jackson","year":"1987","unstructured":"Jackson D, Kinsella TJ, Rowland J, Wright D, Katz D, Main D, Collins J, Kornblith P, Glatstein E: Halogenated pyrimidines as radiosensitizers in the treatment of glioblastoma multiforme. Am J Clin Oncol 10: 437?443, 1987","journal-title":"Am J Clin Oncol"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1200\/JCO.1988.6.5.871","volume":"6","author":"RJ Kinsella","year":"1988","unstructured":"Kinsella RJ, Collins J, Rowland J, Klecker R, Wright D, Katz D, Steinberg SM, Glatstein E: Pharmacology and Phase I\/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme. J Clin Oncol 6: 871?879, 1988","journal-title":"J Clin Oncol"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0360-3016(90)90552-U","volume":"19","author":"TJ Hegarty","year":"1990","unstructured":"Hegarty TJ, Thornton AF, Diaz RF, Chandler W, Ensinger WD, Junck L, Page MA, Gebarski S, Hood TW, Stetson PL, Tankanow RM, McKeever PE, Lichter AS, Greenberg HS: Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomas. Int J Radiat Oncol Biol Phys 19: 421?428, 1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0360-3016(91)90710-L","volume":"21","author":"R Rodriguez","year":"1991","unstructured":"Rodriguez R, Kinsella TJ: Halogenated pyrimidines as radiosensitizers for high grade glioma:revisited. Int J Radiat Oncol Biol Phys 21: 859?862, 1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6?7","key":"CR44","first-page":"396","volume":"148","author":"T Hoshino","year":"1992","unstructured":"Hoshino T: Cell kinetics of glial tumors. Rev Neurol (Paris). 148(6?7): 396?401, 1992","journal-title":"Rev Neurol (Paris)"},{"issue":"4","key":"CR45","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ijc.2910530404","volume":"53","author":"T Hoshino","year":"1993","unstructured":"Hoshino T, Ahn D, Prados MD, Lamborn K, Wilson CB: Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling. Int J Cancer 53(4): 550?555, 1993","journal-title":"Int J Cancer"},{"issue":"1","key":"CR46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0304-3835(92)90025-Q","volume":"64","author":"VN Anisimov","year":"1992","unstructured":"Anisimov VN, Osipova GYu: Two-step carcinogenesis induced by neonatal exposure to 5-bromo-2?-deoxyuridine and subsequent administration of urethan in BALB\/c mice. Cancer Lett 64(1): 75?82, 1992","journal-title":"Cancer Lett"},{"issue":"1","key":"CR47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0027-5107(91)90092-3","volume":"248","author":"KM Call","year":"1991","unstructured":"Call KM, Thilly WG: 5-Azacytidine inhibits the induction of transient TK-deficient cells by 5-bromodeoxyuridine. A novel hypothesis for the facilitation of hypermethylation by 5-bromodeoxyuridine. Mutat Res 248(1): 101?114, 1991","journal-title":"Mutat Res"},{"issue":"12","key":"CR48","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1073\/pnas.85.12.4406","volume":"85","author":"RL Davidson","year":"1988","unstructured":"Davidson RL, Broeker P, Ashman CR: DNA base sequence changes and sequence specificity of bromodeoxyuridine-induced mutations in mammalian cells. Proc Natl Acad Sci, USA 85(12): 4406?4410, 1988","journal-title":"Proc Natl Acad Sci, USA"},{"key":"CR49","first-page":"63","volume":"12","author":"E Freese","year":"1959","unstructured":"Freese E: On the molecular explanation of spontaneous and induced mutation. Brookhaven Symposia in Biology 12: 63?75, 1959","journal-title":"Brookhaven Symposia in Biology"},{"key":"CR50","first-page":"207","volume-title":"Molecular Genetics","author":"E Freese","year":"1963","unstructured":"Freese E: Molecular mechanism of mutations. In: Taylor W (ed) Molecular Genetics, New York, Academic Press, 1963, pp 207?269"},{"issue":"1","key":"CR51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0027-5107(86)90056-4","volume":"163","author":"ER Kaufman","year":"1986","unstructured":"Kaufman ER: Induction of sister-chromatid exchanges by the replication of 5-bromouracil-substituted DNA under conditions of nucleotide-pool imbalance. Mutat Res 163 (1): 41?50, 1986","journal-title":"Mutat Res"},{"issue":"11","key":"CR52","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1128\/MCB.5.11.3092","volume":"5","author":"ER Kaufman","year":"1985","unstructured":"Kaufman ER: Reversion analysis of mutations induced by 5-bromodeoxyuridine mutagenesis in mammalian cells. Mol Cell Biol 5(11): 3092?3096, 1985","journal-title":"Mol Cell Biol"},{"issue":"1","key":"CR53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0027-5107(88)90231-X","volume":"199","author":"ER Kaufman","year":"1988","unstructured":"Kaufman ER: Analysis of mutagenesis and sister-chromatid exchanges induced by 5-bromo-2?-deoxyuridine in somatic hybrids derived from Syrian hamster melanoma cells and Chinese hamster ovary cells. Mutat Res 199(1): 65?74, 1988","journal-title":"Mutat Res"},{"issue":"1?2","key":"CR54","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0027-5107(88)90077-2","volume":"200","author":"ER Kaufman","year":"1988","unstructured":"Kaufman ER: The role of deoxyribonucleotide metabolism in 5-bromo-2?-deoxyuridine mutagenesis in mammalian cells. Mutat Res 200(1?2): 149?155, 1988","journal-title":"Mutat Res"},{"issue":"4","key":"CR55","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/BF01233065","volume":"17","author":"MT Kresnak","year":"1991","unstructured":"Kresnak MT, Davidson RL: Effects of flanking base sequences on 5-bromodeoxyuridine mutagenesis in mammalian cells. Somat Cell Mol Genet 17(4): 399?410, 1991","journal-title":"Somat Cell Mol Genet"},{"issue":"5","key":"CR56","first-page":"495","volume":"23","author":"K Matsuoka","year":"1990","unstructured":"Matsuoka K, Nomura K, Hoshino T: Mutagenic effects of brief exposure to bromodeoxyuridine on mouse FM3A cells. Cell Tissue Kinet 23(5): 495?503, 1990","journal-title":"Cell Tissue Kinet"},{"issue":"1","key":"CR57","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0165-1218(90)90112-F","volume":"241","author":"AF McFee","year":"1990","unstructured":"McFee AF, Tice RR: Influence of treatment to sacrifice time and the presence of BrdUrd on chemically-induced aberration rates in mouse marrow cells. Mutat Res 241(1): 95?108, 1990","journal-title":"Mutat Res"},{"issue":"2","key":"CR58","first-page":"318","volume":"49","author":"NP Napalkov","year":"1989","unstructured":"Napalkov NP, Anisimov VN, Likhachev AJ, Tomatis L: 5 Bromodeoxyuridine-induced carcinogenesis and its modification by persistent estrus syndrome, unilateral nephrectomy, and X-irradiation in rats. Cancer Res 49(2): 318?323, 1989","journal-title":"Cancer Res"},{"issue":"3?4","key":"CR59","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0165-7992(87)90156-4","volume":"191","author":"P Ostrosky-Wegman","year":"1987","unstructured":"Ostrosky-Wegman P, Montero MR, deNava CC, Tice RR, Albertini R: The use of bromodeoxyuridine labeling in the human lymphocyte HGPRT somatic mutation assay. Mutat Res 191(3?4): 211?214, 1987","journal-title":"Mutat Res"},{"issue":"1","key":"CR60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00330936","volume":"217","author":"RG Sargent","year":"1989","unstructured":"Sargent RG, Ji JP, Mun B, Mathews CK: Ribonucleotide reductase: a determinant of 5-bromodeoxyuridine mutagenesis in phage T4. Mol Gen Genet 217(1): 13?19, 1989","journal-title":"Mol Gen Genet"},{"issue":"2","key":"CR61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0027-5107(90)90055-9","volume":"230","author":"Y Shiraishi","year":"1990","unstructured":"Shiraishi Y, Li MJ: Bromodeoxyuridine [BRdU] template and thymidine pool effects on high frequencies of sisterchromatid exchange [SCE] in Bloom syndrome cells and a mutant cell line [AsHA] originated from ataxia telangiectasia. Mutat Res 230(2): 177?186, 1990","journal-title":"Mutat Res"},{"issue":"3","key":"CR62","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0027-5107(74)90029-3","volume":"22","author":"RM Stark","year":"1974","unstructured":"Stark RM, Littlefield JW: Mutagenic effect of BUdR in diploid human fibroblasts. Mutat Res 22(3): 281?286, 1974","journal-title":"Mutat Res"},{"issue":"1","key":"CR63","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0027-5107(89)90105-X","volume":"211","author":"T Taguchi","year":"1989","unstructured":"Taguchi T, Shiraishi Y: Increased sister-chromatid exchanges and chromosomal fragilities by BrDU in a human mutant B-lymphoblastoid cell line. Mutat Res 211(1): 43?49, 1989","journal-title":"Mutat Res"},{"issue":"5","key":"CR64","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF01233197","volume":"16","author":"FM Xu","year":"1990","unstructured":"Xu FM, Greenspan JA, Davidson RL: Replication-dependent mutagenesis by 5-bromodeoxyuridine: identification of base change and sequence effects on mutability. Somat Cell Mol Genet 16(5): 477?486, 1990","journal-title":"Somat Cell Mol Genet"},{"issue":"9","key":"CR65","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/0360-3016(84)90546-7","volume":"10","author":"S Phuphanich","year":"1984","unstructured":"Phuphanich S, Levin EM, Levin VA: Phase I study of intravenous bromodeoxyuridine used concomitantly with radiation therapy in patients with primary malignant brain tumors. Int J Radiat Oncol Biol Phys 10(9): 1769?1772, 1984","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR66","first-page":"1702","volume":"44","author":"A Russo","year":"1984","unstructured":"Russo A, Gianni L, Kinsella TJ, Klecker RW Jr, Jenkins J, Rowland J, Glatstein E, Mitchell JB, Collins J, Myers C: Pharmacological evalution of intravenous delivery of 5 BDU to patients with brain tumors. Cancer Res 44: 1702?1705, 1984","journal-title":"Cancer Res"},{"key":"CR67","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1200\/JCO.1988.6.5.871","volume":"6","author":"RJ Kinsella","year":"1988","unstructured":"Kinsella RJ, Collins J, Rowland J, Klecker R, Wright D, Katz D, Steinberg SM, Glatstein E: Pharmacology and Phase I\/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme. J Clin Oncol 6: 871?879, 1988","journal-title":"J Clin Oncol"},{"issue":"5","key":"CR68","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3171\/jns.1989.70.5.0701","volume":"70","author":"IM Germano","year":"1989","unstructured":"Germano IM, Ito M, Cho KG, Hoshino T, Davis RL, Wilson CB: Correlation of histopathological features and proliferative potential of gliomas. J Neurosurg 70(5): 701?706, 1989","journal-title":"J Neurosurg"},{"key":"CR69","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1227\/00006123-198612000-00003","volume":"19","author":"JA Murovic","year":"1986","unstructured":"Murovic JA, Nagashima T, Hoshino T, Edwards MSB, Davis RL: Pediatric central nervous system tumors: a cell kinetic study with bromodeoxyuridine. Neurosurgery 19: 900?904, 1986","journal-title":"Neurosurgery"},{"issue":"20","key":"CR70","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3171\/jns.1990.73.2.0254","volume":"73","author":"A Asai","year":"1990","unstructured":"Asai A, Shibui S, Barker M, Vanderlaan M, Gray JW, Hoshino T: Cell kinetics of rat 9L brain tumors determined by double labeling with iodo- and bromodeoxyuridine. J Neurosurg 73(20): 254?258, 1990","journal-title":"J Neurosurg"},{"issue":"1","key":"CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.2910500102","volume":"50","author":"T Hoshino","year":"1992","unstructured":"Hoshino T, Ito S, Asai A, Shibuya M, Prados MD, Dodson BA, Davis RL, Wilson CB: Cell kinetic analysis of human brain tumors byin situ double labeling with bromodeoxyuridine and iododeoxyuridine. Int J Cancer 50(1): 1?5, 1992","journal-title":"Int J Cancer"},{"issue":"7","key":"CR72","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1177\/37.7.2659659","volume":"37","author":"S Shibui","year":"1989","unstructured":"Shibui S, Hoshino T, Vanderlaan M, Gray JW: Double labeling with iodo- and bromodeoxyuridine for cell kinetics studies. J Histochem Cytochem 37(7): 1007?1011, 1989","journal-title":"J Histochem Cytochem"},{"key":"CR73","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3171\/jns.1988.69.4.0588","volume":"69","author":"KG Cho","year":"1988","unstructured":"Cho KG, Nagashima T, Barnwell S, Hoshino T: Flow cytometric determination of modal DNA population in relation to proliferative potential of human intracranial neoplasms. J Neurosurg 69: 588?592, 1988","journal-title":"J Neurosurg"},{"issue":"5","key":"CR74","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0277-5379(88)90196-4","volume":"24","author":"M Danova","year":"1988","unstructured":"Danova M, Riccardi A, Gaetani P, Wilson GD, Mazzini G, Brugnatelli S, Buttini R, Butti G, Ucci G, Paoletti P, Ascari E: Cell kinetics of human brain tumors:in vivo study with bromodeoxyuridine and flow cytometry. Eur J Cancer Clin Oncol 24(5): 873?880, 1988","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"7","key":"CR75","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0024-3205(90)90006-D","volume":"46","author":"SK Mukhopadhyay","year":"1990","unstructured":"Mukhopadhyay SK, McKeever PE, Greenberg HS, Junck L, Chandler WF, Ensminger W: Random sampling by glitter drop method. Life Sci 46(7): 507?512, 1990","journal-title":"Life Sci"},{"issue":"3","key":"CR76","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00177357","volume":"8","author":"A Detta","year":"1990","unstructured":"Detta A, Hitchcock E: Rapid estimation of the proliferating index of brain tumors. J Neurooncol 8(3): 245?253, 1990","journal-title":"J Neurooncol"},{"issue":"3","key":"CR77","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/jnci\/84.3.194","volume":"84","author":"K Kharbanda","year":"1992","unstructured":"Kharbanda K, Karak AK, Sarkar C, Dinda AK, Mathur M, Roy S: Prediction of biologic aggressiveness in human meningiomas: a cell kinetic study using bromodeoxyuridine in cells of primary expiant culture. J Natl Cancer Inst 84(3): 194?195, 1992","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"CR78","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/cyto.990080407","volume":"8","author":"S Genka","year":"1987","unstructured":"Genka S, Shitara N, Tsujita Y, Kosugi Y, Wu Y, Takakura K: Cell cycle perturbation of cultured C6 glioma cells following short-term contact with a low dose of ACNU. Cytometry 8(4): 386?391, 1987","journal-title":"Cytometry"},{"issue":"4","key":"CR79","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00177424","volume":"6","author":"S Genka","year":"1988","unstructured":"Genka S, Shitara N, Tsujita Y, Kosugi Y, Takakura K: Effect of interferon-beta on the cell of human glioma cell line U-251 MG: flow cytometric two-dimensional (MrDU\/DNA) analysis. J Neurooncol 6(4): 299?307, 1988","journal-title":"J Neurooncol"},{"issue":"1?2","key":"CR80","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF01400531","volume":"91","author":"T Inoue","year":"1988","unstructured":"Inoue T, Tashima T, Nishio S, Takeshita I, Iwaki T, Fukui M: Vascular permeability and cell kinetics of ethylnitrosourea (ENU)-induced rat brain tumours. Acta Neurochir (Wien) 91(1?2): 67?72, 1988","journal-title":"Acta Neurochir (Wien)"},{"issue":"3","key":"CR81","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF00172595","volume":"14","author":"K Mineura","year":"1992","unstructured":"Mineura K, Watanabe K, Izumi I, Kowarda M: Modulation of BUdR labeling index in rat brain tumors following intracarotid ACNU administration. J Neurooncol 14(3): 201?205, 1992","journal-title":"J Neurooncol"},{"issue":"1","key":"CR82","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00149381","volume":"7","author":"T Morimura","year":"1989","unstructured":"Morimura T: Prolongation of Gl phase in cultured glioma cells by cis-dichlorodiammineplatinum (CDDP): analysis using bromodeoxyuridine (BrDU)-Hoechst technique. J Neurooncol 7(1): 71?79, 1989","journal-title":"J Neurooncol"},{"issue":"9","key":"CR83","first-page":"879","volume":"78","author":"M Tatematsu","year":"1987","unstructured":"Tatematsu M, Fukushima S, Aoki T, Mera Y, Inoue T, Ito N: Patterns of epithelial proliferation revealed by continuous administration of bromodeoxyuridine during urinary bladder carcinogenesis in rats. Jpn J Cancer Res 78(9): 879?882, 1987","journal-title":"Jpn J Cancer Res"},{"issue":"3","key":"CR84","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF00294657","volume":"79","author":"Y Yoshida","year":"1989","unstructured":"Yoshida Y, Kumanishi T, Abe S, Nishiyama A, Yamada M, Hinokuma K: Glomeruloid blood vessels in ethylnitrosourea-induced rat gliomas. Histological and immunohistochemical studies. Acta Neuropathol (Berl) 79(3): 240?247, 1989","journal-title":"Acta Neuropathol (Berl)"},{"key":"CR85","first-page":"170","volume-title":"Modern radiotherapy and oncology: CNS tumors","author":"T Hoshino","year":"1974","unstructured":"Hoshino T: Radiosensitization of brain tumors. In: Deeley TJ (ed) Modern radiotherapy and oncology: CNS tumors. Butterworth, London, 1974, pp 170?184"},{"key":"CR86","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0014-4827(63)90325-2","volume":"30","author":"WC Mohlen","year":"1963","unstructured":"Mohlen WC, Elkind MM: Radiation response of mammalian cells grown in culture. Modification of X-ray survival of Chinese hamster cells by 5BDU. Exp Cell Res 30: 481?491, 1963","journal-title":"Exp Cell Res"},{"key":"CR87","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2307\/3578305","volume":"135","author":"MJ Lindstrom","year":"1993","unstructured":"Lindstrom MJ, Kunugi KA, Kinsella TJ: Global comparison of radiation and chemotherapy dose-response curves with a test for interaction. Radiation Res 135: 269?277, 1993","journal-title":"Radiation Res"},{"key":"CR88","first-page":"21","volume":"19","author":"CJ McGinn","year":"1992","unstructured":"McGinn CJ, Kinsella TJ: The experimental and clinical rationale for the use of S-phase-specific radiosensitizers to overcome tumor cell repopulation. Sem Oncol 19: 21?28, 1992","journal-title":"Sem Oncol"},{"key":"CR89","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3171\/jns.1988.69.3.0410","volume":"69","author":"C Raffel","year":"1988","unstructured":"Raffel C, Deen D, Edwards MSB: Bromodeoxyuridine: a comparison of its photosensitizing and radiosensitizing properties. J Neurosurg 69: 410?415, 1988","journal-title":"J Neurosurg"},{"key":"CR90","first-page":"1687","volume":"52","author":"EM Miller","year":"1992","unstructured":"Miller EM, Kinsella TJ: Radiosensitization by fluorodeoxyuridine: effects of thymidylate synthase inhibitionated cell synchronization. Cancer Res 52: 1687?1694, 1992","journal-title":"Cancer Res"},{"key":"CR91","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/0360-3016(85)90275-5","volume":"11","author":"RJ Kinsella","year":"1985","unstructured":"Kinsella RJ, Russo A, Mitchell JB, Collins JM, Rowland J, Wright D, Glatstein MD: A Phase I study of intravenous iododeoxyuridine as a clinical radiosensitizer. Int J Radiat Oncol Biol Phys 11: 1941?1946, 1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR92","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/0360-3016(86)90207-5","volume":"12","author":"TJ Kinsella","year":"1986","unstructured":"Kinsella TJ, Dobson PP, Mitchell JB: Interaction of iododeoxyuridine and its primary metabolite, iodouracil on radiation response. Int J Radiat Oncol Biol Phys 12: 1519?1522, 1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR93","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0360-3016(90)90410-L","volume":"18","author":"A Fornace","year":"1990","unstructured":"Fornace A, Dobson PP, Kinsella TJ: Enhancement of radiation damage in cellular DNA following unifilar substitution with iododeoxyuridine. Int J Radiat Oncol 18: 873?878, 1990","journal-title":"Int J Radiat Oncol"},{"key":"CR94","first-page":"41","volume":"19","author":"TJ Kinsella","year":"1992","unstructured":"Kinsella TJ: Radiosensitization and cell kinetics: clinical implications for S-phase-specific radiosensitizers. Sem Oncol 19: 41?47, 1992","journal-title":"Sem Oncol"},{"key":"CR95","first-page":"21","volume":"19","author":"CJ McGinn","year":"1992","unstructured":"McGinn CJ, Kinsella TJ: The experimental and clinical rationale for the use of S-phase-specific radiosensitizers to overcome tumor cell repopulation. Sem Oncol 19: 21?28, 1992","journal-title":"Sem Oncol"},{"issue":"5","key":"CR96","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/09553009114552571","volume":"60","author":"N Usami","year":"1991","unstructured":"Usami N, Kobayashi K, Maezawa H, Hieda K, Ishizaka S: Biological effects of Auger processes of bromine on yeast cells induced by monochromatic synchroton X-rays. Int J Radiat Biol 60(5): 757?768, 1991","journal-title":"Int J Radiat Biol"},{"key":"CR97","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/0360-3016(86)90206-3","volume":"12","author":"JB Mitchell","year":"1986","unstructured":"Mitchell JB, Russo A, Kinsella TJ, Glatstein E: The use of non-hypoxic cell sensitizers in radiobiology and radiotherapy. Int J Radiat Oncol Biol Phys 12: 1513?1518, 1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR98","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3171\/jns.1968.28.6.0530","volume":"28","author":"K Sano","year":"1968","unstructured":"Sano K, Hoshino T, Nagai M: Radiosensitization of brain tumor cells with a thymidine analog. J Neurosurg 28: 530?538, 1968","journal-title":"J Neurosurg"},{"issue":"4","key":"CR99","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1227\/00006123-199004000-00011","volume":"26","author":"N Ibayashi","year":"1990","unstructured":"Ibayashi N, Herman MM, Boyd JC, Rubinstein LJ: Relationship of invasiveness to proliferating activity and to cytoskeletal protein production in human neuroepithelial tumors maintained in an organ culture system: use of human cortex and dura as supporting matrices. Neurosurgery 26 (4): 629?637, 1990","journal-title":"Neurosurgery"},{"issue":"3","key":"CR100","first-page":"870","volume":"51","author":"WR Mancini","year":"1991","unstructured":"Mancini WR, Stetson PL, Lawrence TS, Wagner JG, Greenberg HS, Ensminger WD: Variability of 5-bromo-2?-deoxyuridine incorporation into DNA of human glioma cell lines and modulation with fluoropyrimidines. Cancer Res 51(3): 870?874, 1991","journal-title":"Cancer Res"},{"issue":"7","key":"CR101","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/0006-2952(92)90217-7","volume":"43","author":"DS Shewach","year":"1992","unstructured":"Shewach DS, Ellero J, Mancini WR, Ensminger WD: Decrease in TTP pools mediated by 5-bromo-2?-deoxyuridine exposure in a human glioblastoma cell line. Biochem Pharmacol 43(7): 1579?1585, 1992","journal-title":"Biochem Pharmacol"},{"key":"CR102","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1172\/JCI116165","volume":"91","author":"RA Berkman","year":"1993","unstructured":"Berkman RA, Merrill MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, Robertson JT, Ali IU, Oldfield EH: Expression of the vascular permeability factor\/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91: 153?159, 1993","journal-title":"J Clin Invest"},{"key":"CR103","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/1097-0142(19920915)70:4+<1788::AID-CNCR2820701621>3.0.CO;2-L","volume":"70","author":"WK Cavenee","year":"1992","unstructured":"Cavenee WK: Accumulation of genetic defects during astrocytoma progression. Cancer 70: 1788?1193, 1992","journal-title":"Cancer"},{"key":"CR104","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI116185","volume":"91","author":"WK Cavenee","year":"1993","unstructured":"Cavenee WK: A siren song from tumor cells (editorial). J Clin Invest 91: 3, 1993","journal-title":"J Clin Invest"},{"key":"CR105","first-page":"5546","volume":"48","author":"CD James","year":"1988","unstructured":"James CD, Carlbom E, Dumanski JP, Hansen M, Nordenskjold M, Collins VP, Cavenee WK: Clonal genomic alterations in glioma malignancy stages. Cancer Res 48: 5546?5551, 1988","journal-title":"Cancer Res"},{"key":"CR106","first-page":"1684","volume":"51","author":"CD James","year":"1991","unstructured":"James CD, He J, Carlbom E, Nordenskjold M, Cavenee WK, Collins VP: Chromosome 9 deletion mapping reveals interferon alpha and interferon beta-1 gene deletions in human glial tumors. Cancer Res 51: 1684?1688, 1991","journal-title":"Cancer Res"},{"key":"CR107","doi-asserted-by":"crossref","first-page":"8602","DOI":"10.1073\/pnas.87.21.8602","volume":"87","author":"N Sugawa","year":"1990","unstructured":"Sugawa N, Ekstrand AJ, James CD, Collins VP: Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc Natl Acad Sci, USA 87: 8602?8606, 1990","journal-title":"Proc Natl Acad Sci, USA"},{"issue":"3","key":"CR108","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jmv.1890270304","volume":"27","author":"Y Nishibe","year":"1989","unstructured":"Nishibe Y, Inoue YK, Kimura T, Hase A: Enhancement of Inoue-Melnick virus synthesis by 5-bromodeoxyuridine in human meningioma (MG-1) cells. J Med Virol 27(3): 196?200, 1989","journal-title":"J Med Virol"},{"issue":"1","key":"CR109","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0042-6822(87)90191-7","volume":"161","author":"GJ Bubley","year":"1987","unstructured":"Bubley GJ, Balzarini J, Crumpacker CS, deClercq E, Schnipper LE: The effect of (e)-5-(2-bromovinyl)-2?-deoxyuridine on DNA repair and mutagenesis of herpes simplex virus type 1. Virology 161(1): 242?244, 1987","journal-title":"Virology"},{"key":"CR110","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0014-4886(89)90047-2","volume":"103","author":"A Freese","year":"1989","unstructured":"Freese A, Sabel BA, Saltzman WM, During MJ, Langer R: Controlled Release of Catecholamines from a Polymeric Brain Implant:In vitro Characterization. Exp Neurol 103: 234?238, 1989","journal-title":"Exp Neurol"},{"key":"CR111","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1073\/pnas.44.2.112","volume":"44","author":"S Benzer","year":"1958","unstructured":"Benzer S, Freese E: Induction of specific mutations with 5-bromouracil. Proc Natl Acad Sci USA 44: 112?119, 1958","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"CR112","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0027-5107(85)90188-5","volume":"151","author":"HL Liber","year":"1985","unstructured":"Liber HL, Call KM, Mascioli DA, Thilly WG: Mutational and pseudomutational effects of 5-bromodeoxyuridine in human lymphoblasts. Mutat Res 151(1): 95?108, 1985","journal-title":"Mutat Res"},{"issue":"2","key":"CR113","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF01233163","volume":"18","author":"JB Rotstein","year":"1992","unstructured":"Rotstein JB, Kresnak MT, Samadashwily GM, Davidson RL: Analysis of sequence specificity of 5-bromodeoxyuridine-induced reversion in cells containing multiple copies of a mutant gpt gene. Somat Cell Mol Genet 18(2): 179?188, 1992","journal-title":"Somat Cell Mol Genet"},{"issue":"4","key":"CR114","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0272-0590(92)90107-S","volume":"18","author":"Y Oshiro","year":"1992","unstructured":"Oshiro Y, Piper CE, Soelter SG, Balwierz PS, Garriott ML: Genotoxic properties of (E)-5-(2-bromovinyl)-2?-deoxyuridine (BVDU). Fundam Appl Toxicol 18(4): 491?498, 1992","journal-title":"Fundam Appl Toxicol"},{"issue":"2","key":"CR115","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2307\/3576394","volume":"101","author":"GP Raaphorst","year":"1985","unstructured":"Raaphorst GP, Azzam El, Borsa J, Sargent MD:In vitro transformation by bromodeoxyuridine and X irradiation in C3H 10T1\/2 cells. Radiat Res 101(2): 279?291, 1985","journal-title":"Radiat Res"},{"key":"CR116","first-page":"281","volume":"29","author":"WF Morgan","year":"1984","unstructured":"Morgan WF, Wolff S: Effect of bromodeoxyuridine on induced sister chromatid exchanges. Basic Life Sci 29: 281?292, 1984","journal-title":"Basic Life Sci"},{"issue":"1","key":"CR117","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0027-5107(86)90057-6","volume":"163","author":"AT Natarajan","year":"1986","unstructured":"Natarajan AT, Rotteveel AH, van Pieterson J, Schliermann MG: Influence of incorporated 5-bromodeoxyuridine on the frequencies of spontaneous and induced sisterchromatid exchanges, detected by immunological methods. Mutat Res 163(1): 51?55, 1986","journal-title":"Mutat Res"},{"issue":"1","key":"CR118","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0165-7992(92)90073-Q","volume":"282","author":"JH Zhao","year":"1992","unstructured":"Zhao JH, Tohda H, Oikawa A: Camptothecin-induced sister -chromatid exchange dependent on the presence of bromodeoxyuridine and the phase of the cell cycle. Mutat Res 282(1): 49?54, 1992","journal-title":"Mutat Res"},{"issue":"3","key":"CR119","first-page":"357","volume":"20","author":"RX Zhang","year":"1987","unstructured":"Zhang RX, Nagashima T, Hoshino T: Cytotoxic effect and induction of sister chromatid exchange in exponentially growing rat 9L gliosarcoma cells after brief exposure to BrdU. Cell Tissue Kinet 20(3): 357?362, 1987","journal-title":"Cell Tissue Kinet"},{"issue":"3","key":"CR120","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1128\/MCB.1.3.254","volume":"1","author":"CR Ashman","year":"1981","unstructured":"Ashman CR, Davidson RL: Bromodeoxyuridine mutagenesis in mammalian cells is related to deoxyribonucleotide pool imbalance. Mol Cell Biol 1(3): 254?260, 1981","journal-title":"Mol Cell Biol"},{"issue":"6","key":"CR121","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00008469-199210000-00006","volume":"1","author":"MJ Brito","year":"1992","unstructured":"Brito MJ, Filipe MI, Morris RW: Cell proliferation study on gastric carcinoma and non-involved gastric mucosa using a bromodeoxyuridine [BrdU] labeling technique. Eur J Cancer Prev 1(6): 429?435, 1992","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"CR122","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0027-5107(86)90096-5","volume":"161","author":"ER Kaufman","year":"1986","unstructured":"Kaufman ER: Altered CTP synthetase activity confers resistance to 5-bromodeoxyuridine toxicity and mutagenesis. Mutat Res 161(1): 19?27, 1986","journal-title":"Mutat Res"},{"issue":"2","key":"CR123","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cyto.990140207","volume":"14","author":"JR Selden","year":"1993","unstructured":"Selden JR, Dolbeare F, Clair JH, Nichols WW, Miller JE, Kleemeyer KM, Hyland RJ, DeLuca JG: Statistical confirmation that immunofluorescent detection of DNA repair in human fibroblasts by measurement of bromodeoxyuridine incorporation is stoichiometric and sensitive. Cytometry 14(2): 154?167, 1993","journal-title":"Cytometry"},{"issue":"7","key":"CR124","first-page":"3533","volume":"46","author":"T Tsutsui","year":"1986","unstructured":"Tsutsui T, Ts'o PO: Requirement of long progression time for the expression of neoplastic phenotypes following direct perturbation to specific regions of DNA of Syrian hamster embryo cells. Cancer Res 46(7): 3533?3537, 1986","journal-title":"Cancer Res"},{"issue":"5","key":"CR125","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/carcin\/12.5.833","volume":"12","author":"B Kirkhus","year":"1991","unstructured":"Kirkhus B, Olsen WM, Clausen OP: A comparison between the epidermal regenerative responses provoked by a skin irritant and a tumor promoter using anti-BrdUrd\/DNA flow cytometry. Carcinogenesis 12(5): 833?837, 1991","journal-title":"Carcinogenesis"},{"issue":"2","key":"CR126","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0027-5107(87)90313-7","volume":"179","author":"ES Manuilova","year":"1987","unstructured":"Manuilova ES, Lukash LL, Shapiro NI: The action of the tumour promoter, TPA, on mutagenesis induced by different agents. Mutat Res 179(2): 231?236, 1987","journal-title":"Mutat Res"},{"issue":"3","key":"CR127","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0300-483X(91)90008-O","volume":"70","author":"JM Ward","year":"1991","unstructured":"Ward JM, Henneman JR, Ospiova GYu, Anisimov VN: Persistence of 5-bromo-2?-deoxyuridine in tissues of rats after exposure in early life. Toxicology 70(3): 345?352, 1991","journal-title":"Toxicology"},{"key":"CR128","first-page":"369","volume":"369","author":"JM Ward","year":"1991","unstructured":"Ward JM, Weghorst CM, Diwan BA, Konishi N, Lubet RA, Henneman JR, Devor DE: Evaluation of cell proliferation in the kidneys of rodents with bromodeoxyuridine immunohistochemistry or tritiated thymidine autoradiography after exposure to renal toxins, tumor promoters, and carcinogens. Prog Clin Biol Res 369: 369?388, 1991","journal-title":"Prog Clin Biol Res"},{"key":"CR129","volume-title":"Oncogenes and the Molecular Origins of Cancer","author":"RA Weinberg","year":"1989","unstructured":"Weinberg RA: Oncogenes and the Molecular Origins of Cancer. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1989"},{"key":"CR130","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0168-9525(93)90209-Z","volume":"9","author":"B Vogelstein","year":"1993","unstructured":"Vogelstein B, Kinzler KW: The multistep nature of cancer. Trends in Genetics 9: 138?141, 1993","journal-title":"Trends in Genetics"},{"key":"CR131","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(70)91098-6","volume":"1","author":"EF Benedict","year":"1970","unstructured":"Benedict EF, Porter IH, Brown CD, Florentin RA: Cytogenetic diagnosis of malignancy in recurrent menigioma. Lancer 1: 971?973, 1970","journal-title":"Lancer"},{"issue":"2","key":"CR132","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3171\/jns.1990.72.2.0268","volume":"72","author":"K Kunishio","year":"1990","unstructured":"Kunishio K, Mishima N, Matsuhisa T, Tsuno K, Matsumi N, Satoh T, Matsumoto K, Furuta T, Nishimoto A, Shiraishi T: Immunohistochemical demonstration of DNA polymerase alpha in human brain-tumor cells. J Neurosurg 72(2): 268?272, 1990","journal-title":"J Neurosurg"},{"issue":"3","key":"CR133","first-page":"259","volume":"22","author":"S Shibui","year":"1989","unstructured":"Shibui S, Hoshino T, Iwasaki K, Nomura K, Jastreboff MM: Cell cycle phase dependent emergence of thymidylate synthase studied by monoclonal antibody (M-TS-4). Cell Tissue Kinet 22(3): 259?268, 1989","journal-title":"Cell Tissue Kinet"},{"issue":"3?4","key":"CR134","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF01400617","volume":"117","author":"A Sasaki","year":"1992","unstructured":"Sasaki A, Naganuma H, Kimura R, Isoe S, Nakano S, Nukui H, Suzuki K, Kawaoi A: Proliferating cell nuclear antigen (PCNA) immunostaining for brain tumors in paraffin embedded sections. Acta Neurochir (Wien) 117(3?4): 178?181, 1992","journal-title":"Acta Neurochir (Wien)"},{"issue":"5","key":"CR135","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF01605076","volume":"419","author":"A Allegranza","year":"1991","unstructured":"Allegranza A, Girlando S, Arrigoni GL, Veronese S, Mauri FA, Gambacorta M, Polio B, Dalla Palma P, Barbareschi M: Proliferating cell nuclear antigen expression in central nervous system neoplasms. Virchows Arch Pathol Anat Histopathol 419(5): 417?423, 1991","journal-title":"Virchows Arch Pathol Anat Histopathol"},{"key":"CR136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2176\/nmc.27.1","volume":"27","author":"K Tabuchi","year":"1987","unstructured":"Tabuchi K, Honda C, Nakane PK: Demonstration of proliferating cell nuclear antigen (PCNA\/cyclin) in glioma cells. Neurol Med Chir 27: 1?5, 1987","journal-title":"Neurol Med Chir"},{"issue":"1","key":"CR137","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1227\/00006123-199001000-00006","volume":"26","author":"T Orita","year":"1990","unstructured":"Orita T, Kajiwara K, Nishizaki T, Ikeda N, Kamiryo T, Aoki H: Nucleolar organizer regions in menigioma. Neurosurgery 26(1): 43?46, 1990","journal-title":"Neurosurgery"},{"issue":"2","key":"CR138","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02390174","volume":"11","author":"A Hara","year":"1991","unstructured":"Hara A, Niikawa S, Hirayama H, Sakai N, Yamada H, Ohno T, Tanaka T, Mori H: Correlation between nucleolar organizer region score and bromodeoxyuridine labeling index in C6 glioma cell line. J Neurooncol 11(2): 149?155, 1991","journal-title":"J Neurooncol"},{"issue":"1?2","key":"CR139","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0006-8993(92)90492-R","volume":"572","author":"K Kajiwara","year":"1992","unstructured":"Kajiwara K, Orita T, Nishizaki T, Kamiryo T, Nakayama H, Ito H: Glial fibrillary acidic protein (GFAP)expression and nucleolar organizer regions (NORs) in human gliomas. Brain Res 572(1?2): 314?318, 1992","journal-title":"Brain Res"},{"issue":"2","key":"CR140","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF00308919","volume":"80","author":"H Maier","year":"1990","unstructured":"Maier H, Morimura T, Ofner D, Hallbrucker C, Kitz K, Budka H: Argyrophilic nucleolar organizer region proteins (Ag-NORs) in human brain tumors: relations with grade of malignancy and proliferative indices. Acta Neuropathol (Berl) 80(2): 156?162, 1990","journal-title":"Acta Neuropathol (Berl)"},{"issue":"3","key":"CR141","first-page":"310","volume":"61","author":"N Ibayashi","year":"1989","unstructured":"Ibayashi N, Herman MM, Boyd JC, Bigner DD, Friedman HS, Collins VP, Donoso LA, Rubinstein LJ: Relationship of the demonstration of intermediate filament protein to kinetics of three human neuroepithelial tumor cell lines. Lack of neural related proteins in most cells in S phase: a double-labeled immunohistochemical study on matrix cultures. Lab Invest 61(3): 310?318, 1989","journal-title":"Lab Invest"},{"key":"CR142","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00000478-198609000-00003","volume":"10","author":"PC Burger","year":"1986","unstructured":"Burger PC, Shibata T, Kleihues P: The use of monoclonal antibody Ki-67 in the identification of proliferating cells. Application to surgical neuropathology. Am J Surg Pathol 10: 611?617, 1986","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"CR143","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00294647","volume":"80","author":"T Morimura","year":"1990","unstructured":"Morimura T, Neuchrist C, Kitz K, Budka H, Scheiner O, Kraft D, Lassmann H: Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation. Acta Neuropathol (Berl) 80(3): 287?294, 1990","journal-title":"Acta Neuropathol (Berl)"},{"issue":"3","key":"CR144","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3171\/jns.1989.70.3.0379","volume":"70","author":"T Nishizaki","year":"1989","unstructured":"Nishizaki T, Orita T, Furutani Y, Ikeyama Y, Aoki H, Sasaki K: Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors. J Neurosurg 70(3): 379?384, 1989","journal-title":"J Neurosurg"},{"issue":"6","key":"CR145","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0890-8508(05)80015-5","volume":"5","author":"A Detta","year":"1991","unstructured":"Detta A, Hitchcock E: Rapid detection of gene expression. Mol Cell Probes 5(6): 437?443, 1991","journal-title":"Mol Cell Probes"},{"key":"CR146","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0165-4608(87)90140-3","volume":"26","author":"Saadi A Al","year":"1987","unstructured":"Al Saadi A, Latimer F, Madercic M, Robbins T: Cytogenetic studies of brain tumors and their clinical significance. Cancer Genet Cytogenet 26: 127?141, 1987","journal-title":"Cancer Genet Cytogenet"},{"key":"CR147","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0090-3019(85)90180-6","volume":"24","author":"HJ Jaakelainen","year":"1985","unstructured":"Jaakelainen HJ, Haltia M, Laassonen E, Wohlstrom T, Valtonen S: The growth rate of intracranial meningiomas and its relation to histology. An analysis of 43 cases. Surg Neurol 24: 165?172, 1985","journal-title":"Surg Neurol"},{"key":"CR148","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0165-4608(88)90218-X","volume":"31","author":"EL Maltby","year":"1988","unstructured":"Maltby EL, Ironside JW, Battersby RDE: Cytogenetic studies in 50 meningiomas. Cancer Genet Cytogenet 31: 199?210, 1988","journal-title":"Cancer Genet Cytogenet"},{"issue":"6","key":"CR149","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1227\/00006123-199306000-00002","volume":"32","author":"AM Vagner-Capodano","year":"1993","unstructured":"Vagner-Capodano AM, Grisoli F, Gambarelli D, Sedan R, Pellet W, De Victor B: Correlation between cytogenetic and histopathological findings in 75 human meningiomas. Neurosurgery 32(6): 892?900, 1993","journal-title":"Neurosurgery"},{"key":"CR150","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000393683","volume":"17","author":"CB Wilson","year":"1972","unstructured":"Wilson CB, Hoshino T, Barber M, Downey R: Kinetics of gliomas in rat and man. Progr Exp Tumor Res 17: 363?372, 1972","journal-title":"Progr Exp Tumor Res"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01057964.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01057964\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01057964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T04:51:49Z","timestamp":1556599909000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01057964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994]]}},"alternative-id":["BF01057964"],"URL":"https:\/\/doi.org\/10.1007\/bf01057964","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994]]}}}